Hemoglobin A1c (your average glucose over about three months) and fasting glucose both tend to fall, often within the first few weeks
The innovator develops a next-generation version of its product an extended-release formulation, a new dosing schedule, a fixed-dose combination with another drug, a new delivery device, or a new concentration with its own patent protection extending beyond the original products CoM expiration
Tirzepatide activates both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, whereas semaglutide targets only GLP-1
When combined with healthy lifestyle habits, it can help patients achieve meaningful progress while supporting sustainable results
Side effects and safety Both medicines are generally well tolerated, and most side effects are mild to moderate, especially during the first few weeks of treatment
These three enzymes collectively handle the biotransformation of a substantial proportion of all pharmaceuticals